A randomized and controlled trial about the use of oral isotretinoin for photoaging

International Journal of Dermatology

Volumn 49, Issue 2, 2010, Pages 207-214

  Bagatin, Ediléia ^a   Parada, Meire O B ^a   Miot, Hélio A ^b   Hassun, Karime M ^a   Michalany, Nilceo ^a   Talarico, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ISOTRETINOIN; PROTEIN P53; SUNSCREEN;

ADULT; ARTICLE; CHEILITIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DRY NOSE; ELASTICITY; EPIDERMIS; FEMALE; FEMALE STERILITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IRRITANT DERMATITIS; MENOPAUSE; PHASE 2 CLINICAL TRIAL; PHOTOAGING; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN BIOPSY; SKIN TEST; SKINFOLD THICKNESS; XEROPHTHALMIA; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; RISK ASSESSMENT; SKIN AGING; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 74949134508     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04310.x     Document Type: Article

References (53)

1. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138: 1462-1470.
2. Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron 2004; 35: 155-159
3. Yaar M, Eller M. Mechanisms of aging. Arch Dermatol 2002; 138: 1429-1432.
4. Rabe JH, Mamelak AJ, McElgunn PJS, et al. Photoaging: mechanisms and repair. J Am Acad Dermatol 2006; 55: 1-19.
5. Pillai S, Oresajo C, Hayward J. Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation - a review. Int J Cosmet Sci. 2005; 27: 17-34.
6. Damiani E, Rosati L, Castagna R, et al. Changes in ultraviolet absorbance and hence in protective efficacy against lipid peroxidation of organic sunscreens after UVA irradiation. J Photochem Photobiol B 2006; 82: 204-213.
7. Lefebvre P, Martin PJ, Flajollet S, et al. Transcriptional activities of retinoic acid receptors. Vitam Horm 2005; 70: 199-264.
8. Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15: 836-859.
9. Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence based analysis. J Am Acad Dermatol 1998; 39: S55-S61.
10. Kang S. The mechanism of action of topical retinoids. Cutis 2005; 75(Suppl. 2): 10-13; discussion 13.
11. Stratigos AJ, Katsambas AD. The role of topical retinoids in the treatment of photoaging. Drugs 2005; 65: 1061- 1072.
12. Maddin S, Lauharanta J, Agache P, et al. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebocontrolled trial. J Am Acad Dermatol 2000; 42: 56-63.
13. Kafi R, Kwak HS, Schumacher WE, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol 2007; 143: 606-612.
14. Zelenkova H. Prospective effect of a broad spectrum UVAUVB sunscreen in the retinoid therapy during summer season. J Eur Acad Dermatol Venereol 2003; 17: 311.
15. Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 2006; 20: 773-776.
16. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-663.
17. Goldsmith LA, Bolognia JL, Callen JP, et al. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 2004; 50: 900- 906.
18. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: S150-S157.
19. Hernandez-Perez E, Khawaja HA, Alvarez TYM. Oral isotretinoin as part of the treatment of cutaneous aging. Dermatol Surg 2000; 26: 649-652.
20. Kalil CL, Fachinello FZ, Lamb FM, Comunello LN. Use of oral isotretinoin in photoaging therapy. Skinmed 2008; 7: 10-14.
21. Fitzpatrick TB. The validity and practicality of sunreactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
22. Glogau RG. Chemical peeling and aging skin. J Geriatr Dermatol 1994; 2: 30-35.
23. Miot HA, Paixão MP, Paschoal FM. Fundamentos da fotografia digital em dermatologia. An Bras Dermatol. 2006; 81: 174-180.
24. Abramoff MD, Magalhães PJ, Ram SJ. Image processing with image J. Biophotonics International 2004; 11: 36-42.
25. Flotte TJ, Seddon JM, Zhang YQ, et al. A computerized image analysis method for measuring elastic tissue. J Invest Dermatol 1989; 93: 358-362.
26. Wolf DE, Samarasekera C, Swedlow JR Quantitative analysis of digital microscope images. Methods Cell Biol 2007; 81: 365-396.
27. Lee ES, Kim JH, Im S, et al. Application of computerized image analysis in pigmentary skin diseases. Int J Dermatol 2001; 40: 45-49.
28. Landis JR, Koch GG. The measurement of observer agreeement for categorical data. Biometrics 1977; 33: 159-174.
29. Rokhsar CK, Lee S, Fitzpatrick RE. Review of photorejuvenation: devices, comeceuticals, or both? Dermatol Surg 2005; 31: 1166-1178; discussion 1178.
30. Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006; 1: 327- 348.
31. Fulton JE, Porumb S. Chemical peels: their place within the range of resurfacing techniques. Am J Clin Dermatol 2004; 5: 179-187.
32. Roy D. Ablative facial resurfacing. Dermatol Clin 2005; 23: 549-559.
33. Dierickx CC, Anderson RR. Visible light treatment of photoaging. Dermatol Ther 2005; 18: 191-208.
34. Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: part 1. Increased elastic tissue and solar elastotic syndromes. J Am Acad Dermatol 2004; 51: 1-21.
35. McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45: S188-S194.
36. Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006; 142: 1055-1057.
37. De Marchi MA, Maranhão RC, Brandizzi LI, Souza DR. Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne. Arch Dermatol Res 2006; 297: 403-408.
38. Nau H. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 2001; 45: S183-S187.
39. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000; 136: 1231-1236.
40. Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression. Can J Clin Pharmacol. 2007; 14: 227-233
41. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2007; 26: 210-220.
42. Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54: 644-646.
43. Akman A, Durusoy C, Senturk M, et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 2007; 299: 467-473.
44. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dosis oral isotretinoin in rosacea. Arch Dermatol 1994; 130: 319- 324.
45. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhea and acne. Dermatology 1998; 196: 140-147.
46. Harwood CA, Leedham-Green M, Leigh IM, Proby CM. Low-dose retinoids in the prevention of squamous cell carcinoma in transplant patients: a 16-year retrospective study. Arch Dermatol 2005; 141: 456-464.
47. Bath-Hextall F, Leonardi-Bee J, Somchand N, et al. Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev. 2007; 4: CD005414.
48. Lens M, Medenica L. Systemic retinoids in chemoprevention of non-melanoma skin cancer. Expert Opin Pharmacother 2008; 9: 1363-1374.
49. Jones E, Korzenko A, Kriegel D. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma. J Drugs Dermatol 2004; 3: 498-502.
50. Rubino C, Farace F, Dessy LA, et al. A prospective study of anti-aging topical therapies using a quantitative method of assessment. Plast Reconstr Surg 2005; 115: 1156-1162.
51. Weiss RA, McDaniel DH, Geronemus RG, Weiss MA. Clinical trial of a novel non-thermal LED array for reversal of photoaging: clinical, histological and surface profilometric results. Lasers Surg Med 2005; 36: 85-91.
52. Bagatin E. Isotretinoína. In: Kaminsky A, ed. org. Acné: Un Enfoque Global. Buenos Aires: Pinter, 2007: p.108- 128.
53. Sampaio SAP, Bagatin E. Experiência de 65 anos no tratamento da acne e de 26 anos com isotretinoína oral. An Bras Dermatol 2008; 83: 247-259.